These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35156181)

  • 41. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments.
    Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV
    Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese.
    Wang P; Li MH; Liu GG; Thumboo J; Luo N
    Eur J Health Econ; 2015 Nov; 16(8):857-63. PubMed ID: 25260384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EQ-5D-5L Valuation for the Malaysian Population.
    Shafie AA; Vasan Thakumar A; Lim CJ; Luo N; Rand-Hendriksen K; Md Yusof FA
    Pharmacoeconomics; 2019 May; 37(5):715-725. PubMed ID: 30535779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice.
    Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
    Value Health; 2019 Jan; 22(1):38-44. PubMed ID: 30661632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The EQ-5D-5L Valuation study in Thailand.
    Pattanaphesaj J; Thavorncharoensap M; Ramos-Goñi JM; Tongsiri S; Ingsrisawang L; Teerawattananon Y
    Expert Rev Pharmacoecon Outcomes Res; 2018 Oct; 18(5):551-558. PubMed ID: 29958008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EQ-5D-5L Population Norms and Health Inequality in Colombia.
    Bailey HH; Janssen MF; Varela RO; Moreno JA
    Value Health Reg Issues; 2021 Dec; 26():24-32. PubMed ID: 33773292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cross-sectional study on the determinants of health-related quality of life in the Philippines using the EQ-5D-5L.
    Cheng KJG; Rivera AS; Miguel RTDP; Lam HY
    Qual Life Res; 2021 Aug; 30(8):2137-2147. PubMed ID: 33677770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health literacy and logical inconsistencies in valuations of hypothetical health states: results from the Canadian EQ-5D-5L valuation study.
    Al Sayah F; Johnson JA; Ohinmaa A; Xie F; Bansback N;
    Qual Life Res; 2017 Jun; 26(6):1483-1492. PubMed ID: 28124280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Examining the transnational health preferences of a group of Eastern European migrants relative to a European host population using the EQ-5D-5L.
    Kelleher D; Barry L; Hobbins A; O'Neill S; Doherty E; O'Neill C
    Soc Sci Med; 2020 Feb; 246():112801. PubMed ID: 31972377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Swedish experience-based value sets for EQ-5D health states.
    Burström K; Sun S; Gerdtham UG; Henriksson M; Johannesson M; Levin LÅ; Zethraeus N
    Qual Life Res; 2014 Mar; 23(2):431-42. PubMed ID: 23975375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New methods for modelling EQ-5D-5L value sets: An application to English data.
    Feng Y; Devlin NJ; Shah KK; Mulhern B; van Hout B
    Health Econ; 2018 Jan; 27(1):23-38. PubMed ID: 28833854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality-of-life valuations of advanced breast cancer by New Zealand women.
    Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
    Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].
    Lamers LM; Stalmeier PF; McDonnell J; Krabbe PF; van Busschbach JJ
    Ned Tijdschr Geneeskd; 2005 Jul; 149(28):1574-8. PubMed ID: 16038162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring the Impact of Adding a Respiratory Dimension to the EQ-5D-5L.
    Hoogendoorn M; Oppe M; Boland MRS; Goossens LMA; Stolk EA; Rutten-van Mölken MPMH
    Med Decis Making; 2019 May; 39(4):393-404. PubMed ID: 31092111
    [No Abstract]   [Full Text] [Related]  

  • 55. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations.
    Al Sayah F; Mladenovic A; Gaebel K; Xie F; Johnson JA
    Qual Life Res; 2016 Jan; 25(1):35-43. PubMed ID: 26216584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EQ-5D-5L Slovenian population norms.
    Prevolnik Rupel V; Ogorevc M
    Health Qual Life Outcomes; 2020 Oct; 18(1):333. PubMed ID: 33028345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small differences in EQ-5D-5L health utility scores were interpreted differently between and within respondents.
    McClure NS; Xie F; Paulden M; Ohinmaa A; Johnson JA
    J Clin Epidemiol; 2022 Feb; 142():133-143. PubMed ID: 34737062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
    Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
    Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of EQ-5D-5L questionnaire in patients suffering from urinary incontinence.
    Garcia-Gordillo MA; Collado-Mateo D; Olivares PR; Adsuar JC
    Actas Urol Esp; 2016 Sep; 40(7):457-62. PubMed ID: 26975979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.